NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference43 articles.
1. Current management of portal hypertension;Bosch;J Hepatol,2003
2. Complications of cirrhosis. I. Portal hypertension;Bosch;J Hepatol,2000
3. The management of portal hypertension: rational basis, available treatments and future options;Bosch;J Hepatol,2008
4. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings;Casado;Gastroenterology,1998
5. Portal pressure, presence of gastroesophageal varices and variceal bleeding;Garcia-Tsao;Hepatology (Baltimore, Md),1985
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension;International Journal of Molecular Sciences;2023-11-27
2. Reactivity of renal and mesenteric resistance vessels to angiotensin II is mediated by NOXA1/NOX1 and superoxide signaling;American Journal of Physiology-Renal Physiology;2023-04-01
3. Multifaceted involvements of Paneth cells in various diseases within intestine and systemically;Frontiers in Immunology;2023-03-13
4. Pre‐clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis;Journal of Cellular and Molecular Medicine;2023-01-19
5. Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension;BMC Genomics;2023-01-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3